College of Nursing & Health Sciences, University of Massachusetts Boston, 100 Morrissey Boulevard, Boston, MA, 02125, USA.
Department of Nursing, MGH Institute of Health Professions, MA, Boston, USA.
BMC Public Health. 2021 Jan 6;21(1):41. doi: 10.1186/s12889-020-10033-8.
Women of reproductive age 15-49 are at a high risk of iron-deficiency anemia, which in turn may contribute to maternal morbidity and mortality. Common causes of anemia include poor nutrition, infections, malaria, HIV, and treatments for HIV. We conducted a secondary analysis to study the prevalence of and associated risk factors for anemia in women to elucidate the intersection of HIV and anemia using data from 3 cycles of Zimbabwe Demographic and Health Survey (ZDHS) conducted in 2005, 2010, and 2015.
DHS design comprises of a two-stage cluster-sampling to monitor and evaluate indicators for population health. A field hemoglobin test was conducted in eligible women. Anemia was defined as hemoglobin < 11.0 g/dL in pregnant women; < 12.0 in nonpregnant women. Chi-squared test and multivariable logistic regression analysis accounting for complex survey design were used to determine the prevalence and risk factors associated with anemia.
Prevalence (95% confidence interval (CI)) of anemia was 37.8(35.9-39.7), 28.2(26.9-29.5), 27.8(26.5-29.1) in 2005, 2010, and 2015, respectively. Approximately 9.4, 7.2, and 6.1%, of women had moderate anemia; (Hgb 7-9.9) while 1.0, 0.7, and 0.6% of women had severe anemia (Hgb < 7 g/dL)), in 2005, 2010, and 2015, respectively. Risk factors associated with anemia included HIV (HIV+: 2005: OR (95% CI) = 2.40(2.03-2.74), 2010: 2.35(1.99-2.77), and 2015: 2.48(2.18-2.83)]; Residence in 2005 and 2010 [(2005: 1.33(1.08-1.65), 2010: 1.26(1.03-1.53)]; Pregnant or breastfeeding women [2005: 1.31(1.16-1.47), 2010: 1.23(1.09-1.34)]; not taking iron supplementation [2005: 1.17(1.03-1.33), 2010: 1.23(1.09-1.40), and2015: 1.24(1.08-1.42)]. Masvingo, Matebeleland South, and Bulawayo provinces had the highest burden of anemia across the three DHS Cycles. Manicaland and Mashonaland East had the lowest burden.
The prevalence of anemia in Zimbabwe declined between 2005 and 2015 but provinces of Matebeleland South and Bulawayo were hot spots with little or no change HIV positive women had higher prevalence than HIV negative women. The multidimensional causes and drivers of anemia in women require an integrated approach to help ameliorate anemia and its negative health effects on the women's health. Prevention strategies such as promoting iron-rich food and food fortification, providing universal iron supplementation targeting lowveld provinces and women with HIV, pregnant or breastfeeding are required.
15-49 岁的育龄妇女处于缺铁性贫血的高风险中,而缺铁性贫血反过来又可能导致孕产妇发病率和死亡率上升。贫血的常见原因包括营养不良、感染、疟疾、艾滋病毒以及艾滋病毒的治疗。我们进行了二次分析,以研究使用 2005 年、2010 年和 2015 年三次津巴布韦人口与健康调查(ZDHS)的数据来阐明艾滋病毒和贫血之间的关系,研究了育龄妇女贫血的患病率和相关危险因素。
DHS 设计包括两阶段的聚类抽样,以监测和评估人口健康指标。对符合条件的妇女进行现场血红蛋白检测。贫血定义为孕妇血红蛋白<11.0g/dL;非孕妇血红蛋白<12.0g/dL。采用卡方检验和多变量逻辑回归分析,考虑到复杂的调查设计,以确定贫血的患病率和相关危险因素。
2005 年、2010 年和 2015 年贫血的患病率(95%置信区间(CI))分别为 37.8%(35.9-39.7)、28.2%(26.9-29.5)和 27.8%(26.5-29.1)。2005 年、2010 年和 2015 年,约有 9.4%、7.2%和 6.1%的妇女患有中度贫血(Hgb 7-9.9),而 1.0%、0.7%和 0.6%的妇女患有严重贫血(Hgb <7g/dL)),2005 年、2010 年和 2015 年分别为 0.7%和 0.6%。与贫血相关的危险因素包括艾滋病毒(HIV+:2005 年:比值比(95%CI)=2.40(2.03-2.74),2010 年:2.35(1.99-2.77),2015 年:2.48(2.18-2.83));2005 年和 2010 年的居住地[2005 年:1.33(1.08-1.65),2010 年:1.26(1.03-1.53)];孕妇或哺乳期妇女[2005 年:1.31(1.16-1.47),2010 年:1.23(1.09-1.34)];未服用铁补充剂[2005 年:1.17(1.03-1.33),2010 年:1.23(1.09-1.40),2015 年:1.24(1.08-1.42)]。在三次 DHS 周期中,马绍纳兰、南马塔贝莱兰和布拉瓦约省的贫血负担最高。马尼卡兰和马绍纳兰东的负担最低。
津巴布韦的贫血患病率在 2005 年至 2015 年间有所下降,但南马塔贝莱兰和布拉瓦约省仍是艾滋病毒阳性妇女患病率高于艾滋病毒阴性妇女的热点地区,且变化不大。妇女贫血的多维度原因和驱动因素需要采取综合方法来帮助改善贫血及其对妇女健康的负面影响。需要采取预防策略,如促进富含铁的食物和食物强化,针对低地省份和感染艾滋病毒、孕妇或哺乳期妇女的妇女普遍提供铁补充剂。